Adverse reproductive outcome induced by parvovirus B19 and TORCH infections in women with high-risk pregnancy

Journal of Infection in Developing Countries

Volumn 5, Issue 12, 2011, Pages 868-873

  Kishore, Janak ^a   Misra, Richa ^a   Paisal, Abhiruchi ^b   Pradeep, Yashodhra ^b  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Abortion; BOH; Congenital malformation; Hydrops fetalis; Parvovirus B19; Pregnancy complications; TORCH

Indexed keywords

IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY;

ABORTION; ADULT; ADVERSE OUTCOME; ARTICLE; CONGENITAL MALFORMATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; FEMALE; FETUS HYDROPS; GESTATIONAL AGE; HEART DISEASE; HERPES SIMPLEX VIRUS; HIGH RISK PREGNANCY; HUMAN; HUMAN PARVOVIRUS B19; HYDRAMNIOS; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; OLIGOHYDRAMNIOS; PARITY; PARVOVIRUS INFECTION; PREGNANCY COMPLICATION; REPRODUCTION; RUBELLA VIRUS; SEROLOGY; STILLBIRTH; TOXOPLASMA GONDII; TOXOPLASMOSIS;

EID: 83755225544     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.1533     Document Type: Article

References (24)

1. Stegmann BJ and Carey JC (2002) TORCH Infections: Toxoplasmosis, Other (syphilis, varicella zoster, parvovirus B19, Rubella, Cytomegalovirus (CMV), and Herpes infections. Curr Womens Health Rep 2: 253-258.
2. Kishore J, Agarwal J, Agrawal S, Ayyagari A (2003) Seroanalysis of Chlamydia trachomatis and S-TORCH agents in women with recurrent spontaneous abortions. Indian J Path Microbiol 46: 684-687.
3. Abdul-Karim ET, Abdul-Muhymen N, Al-Saadie M (2009) Chlamydia trachomatis and rubella antibodies in women with full-term deliveries and women with abortion in Baghdad. East Mediterr Health J 15: 1407-1411.
4. Kishore J and Kapoor A (2000) Erythrovirus B19 infection in humans. Indian J Med Res 112: 149-154.
5. Das S, Ramachandran VG, Arora R (2007) Cytomegalovirus and rubella infection in children and pregnant mothers: a hospital based study. J Commun Dis 39: 113-117.
6. Public Health Laboratory Service Working Party on Fifth Disease (1990) Prospective study of human parvovirus B19 infection in pregnancy. Br Med J 30: 1166-1170.
7. Kishore J and Gupta I (2006) Serological study of Parvovirus B19 infection in women with recurrent spontaneous abortions. Indian J Pathol Microbiol 49: 548-5450.
8. Hemauer A, von Poblotzki A, Gigler A, Cassinotti P, Siegl G, Wolf H, Modrow S (1996) Sequence variability among different parvovirus B19 isolates. J Gen Virol 77: 1781-1785.
9. Ajayi GO and Omilabu SA (2010) Prenatal diagnoses of cytomegalovirus (CMV), rubella, toxoplasmosis, varicella, parvovirus, herpes simplex and syphilis. The Lagos programme experience. Clin Exp Obstet Gynecol 37: 37-38.
10. Jones CA (2009) Vertical transmission of genital herpes: prevention and treatment options. Drugs 69: 421-434.
11. Surpam RB, Kamlakar UP, Khadse RK, Qazi MS, Jalgaonkar SV (2006) Serological study for TORCH infections in women with bad obstetric history. J Obstet Gynecol India 56: 41-43.
12. Turbadkar D, Mathur M, Rele M (2003) Seroprevalence of torch infection in bad obstetric history. Indian J Med Microbiol 21: 108-110.
13. Tamer GS, Dundar D, Caliskan E (2009) Seroprevalence of Toxoplasma gondii, rubella and cytomegalovirus among pregnant women in western region of Turkey. Clin Invest Med 32: E43-47.
14. Schmid D, Kasper S, Kuo HW, Aberle S, Holzmann H, Daghofer E, Wassermann-Neuhold M, Feenstra O, Krischka C, Allerberger F (2009) Ongoing rubella outbreak in Austria 2008-2009. Eurosurveillance 23:14.
15. Kishore J, Broor S, Seth P (1990) Acute rubella infection in pregnant women in Delhi. Indian J Med Res [A] 91: 245-246
16. Syridou G, Spanakis N, Konstantindou A, Piperaki ET, Kafetzis D, Patsouris E, Antsaklis A, Tsakris A (2008) Detection of Cytomegalovirus, parvovirus B19 and herpes simplex viruses in cases of intrauterine fetal death: association with pathologic findings. J Med Virol 80: 177.
17. Broor S, Kapil A, Kishore J, Seth P (1991) Prevalence of Rubella Virus and Cytomegalovirus Infections in Suspected cases of Congenital Infections. Indian J Pediatric58: 75-78.
18. Amoda C, Doyle S (2004) Advances in the biology, diagnosis and host pathogen interaction of parvovirus B19. J Microbiol 3: 459-475.
19. Harger JH, Adler SP, Koch WC, Harger GF (1998) Prospective evaluation of 618 pregnant women exposed to parvovirus B19: risks and symptoms. Obstet Gynecol 91: 413-420.
20. Crane J (2002) Society of Obstetricians and Gynaecologists of Canada Parvovirus B19 infection in pregnancy. J Obstet Gynaecol Can 24: 727-743.
21. Enders M, Weidner A, Rosenthal T, Baisch C, Hedman L, Soderlund-Venermo M, Hedman K (2008) Improved diagnosis of gestational parvovirus B19 at the time of nonimmune fetal hydrops. J Infect Dis 197: 58-62.
22. Tiessen RG, van Elsacker-Niele AM, Vermeij-Keers C, Oepkes D, van Roosmalen J, Gorsira MC (1994) A foetus with a parvovirus B19 infection and congenital anomalies. Prenat Diagn 14: 173-176.
23. Cunnigham F, Lenovo K, Bloom S, Hauth J, Rouse D, Spong C (2010) Williams Obstetrics, 23rd edition. Berkshire, UK: McGraw-Hill 1404 p.
24. Voigt HJ, Grünsteidel W, Faschingbauer C, Voigt HJ, Grünsteidel W, Faschingbauer C (1989) Prenatal diagnosis and prognosis of oligo-anhydramnios. Geburtshilf Frauenheilkd 49: 350-356.